glucose 10 % w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose 10 % w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose 10 % w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 10 percent weight/weight - solutions for parenteral nutrition; carbohydrates
glucose 5 % w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/weight - solutions for parenteral nutrition; carbohydrates
glucose 5% w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose 5% w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose 5% w/v solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates
glucose 5% w/v, solution for infusion
fresenius kabi deutschland gmbh - glucose anhydrous - solution for infusion - 5 percent weight/volume - solutions for parenteral nutrition; carbohydrates
sodium chloride 0.3% and glucose 3.3% solution for infusion baxter
teva israel ltd - glucose as monohydrate; sodium chloride - solution for infusion - glucose as monohydrate 33 g/l; sodium chloride 3 g/l - electrolytes with carbohydrates - a source of water supply, electrolytes and calories
glucose 10% w/v
fresenius kabi new zealand limited - glucose monohydrate 110 g/l equivalent to glucose 100 g/l; - solution for infusion - 100 g/l - active: glucose monohydrate 110 g/l equivalent to glucose 100 g/l excipient: hydrochloric acid sodium hydroxide water for injection - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used. b) gastrointestinal absorption of protein is impaired. c) metabolic requirements for protein are substantially increased, as with extensive burns.